Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:24 PM
Ignite Modification Date:
2025-12-24 @ 7:24 PM
NCT ID:
NCT03559803
Eligibility Criteria:
Inclusion Criteria:
1. Age:18-70 years.
2. All FIGO stages cervical cancers which are the matter for radiochemotherapy and exclusive brachytherapy indications.
3. ECOG:0-1.
4. Ability to give informed consent.
4\. Patients must be affiliated to a Social Security System. 6. Patient information and written informed consent form signed.
Exclusion Criteria:
1. Known autoimmune disorder.
2. History of HIV and/ or active hepatitis infection.
3. History of pelvic radiation or radio-chemotherapy.
4. Recurrent or metastatic cervical cancer.
5. Contra-indication for cisplatin.
6. Patient pregnant and/or breastfeeding.
7. Patients with psychological or familial disease potentially hampering compliance with the study protocol and follow-up schedule
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT03559803
Study Brief:
Protocol Section:
NCT03559803